Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. This price target is based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. ... Albireo Pharma… The firm had revenue of $1.91 million for the quarter, compared to analyst estimates of $1.53 million. 07:59 AM ET. Jun-09-20 07:30AM : Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022. GlobeNewswire. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.65) by $0.27. On 2020-10-19, Albireo Pharma (ALBO-Q) stock closed at a price of $34.31. Please note that any opinions, estimates or forecasts regarding Albireo's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Albireo … Post-Market 0.08 (0.20%) In depth view into ALBO (Albireo Pharma) stock including the latest price, news, dividend history, earnings information and financials. Statistics highlight that Albireo Pharma, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. Zacks. Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Albireo Pharma started at buy with $40 stock price target at … Albireo Pharma Inc (ALBO:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Albireo Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Albireo Pharma, Inc. (ALBO) estimates and forecasts. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Albireo Pharma. ALBO updated stock price target summary. Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies. Albireo Pharma stock price target cut to $60 from $69 at Wedbush Mar. Albireo Pharma earnings estimates module stress-tests analyst consensus about projected Albireo Pharma EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. 07:59 AM ET. What this means: Albireo Pharma Inc (ALBO) gets a very positive evaluation from InvestorsObserver's ranking system. During that period the price should oscillate between -12.06% and +14.58%. Albireo Pharma (NASDAQ:ALBO) Earnings Information. Friday, May 18, 2018. Albireo Pharma is projected to generate -7.4514 in earnings per share on 31st of December 2020. ALBO stock forecast Our latest prediction for Albireo Pharma, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 39.98$. On average, 7 Wall Street analysts forecast ALBO's earnings for 2020 to be $-101,390,514, with the lowest ALBO earnings forecast Is ALBO a good stock to buy now? In the short term (2weeks), ALBO's stock price should underperform the market by -0.61%. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. About Albireo Who We Are. The average price target represents a 63.60% upside from the last price of $41.74. ALBO, Albireo Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Albireo Pharma's earnings in 2020 is -$81,523,000. ALBIREO PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ALBIREO PHARMA, INC. Stock | ALBO | The number of bullish hedge fund bets improved by 10 recently. Find the latest analyst research for Albireo Pharma, Inc. Common Stock (ALBO) at Nasdaq.com. The best stock pickers were becoming hopeful. Thursday, February 16, 2017. Detailed list of analyst forecasts Albireo is followed by the analysts listed above. The average price target represents a 90.61% increase from the last price of $36.95. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.65) by $0.27. Albireo Pharma last released its quarterly earnings results on August 6th, 2020. Stock Alert: Albireo Pharma Soars 70% As Liver Drug's Late-Stage Trial Met Primary Goals Business Insider 9/8/2020. Why Albireo Pharma (ALBO) Stock Might be a Great Pick. Jun-10-20 08:00AM : Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments. Albireo Pharma last posted its quarterly earnings data on August 6th, 2020. Albireo Pharma has generated ($5.04) earnings per … Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann MarketWatch. See Albireo Pharma, Inc. (ALBO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. ET by Tomi Kilgore Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann The company added +198.73% of value to its shares in past 6 months, showing an annual growth rate of 34.33% while that of … Who this matters to: Overall Ranking is a comprehensive … The average price target is $70.43 with a high forecast of $81.00 and a low forecast of $65.00. View today's stock price, news and analysis for Albireo Pharma Inc. (ALBO). The average price target is $68.29, with a high forecast of $81.00 and a low forecast of $52.00. Albireo Pharma stock price target raised to $69 vs. $63 at Wedbush MarketWatch. 3, 2020 at 7:39 a.m. Please continue to … ALBO 40.78 0.47 (1.14%). Webull offers kinds of Albireo Pharma Inc stock information, including NASDAQ:ALBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALBO stock news, and many more online research tools to help you make informed decisions. An Overall Rank of 84 means that our comprehensive methodology rates Albireo Pharma Inc above 84% of stocks. ALBO Stock Analysis Overview . What is Albireo Pharma stock price? Find real-time GTHX - G1 Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Get Albireo Pharma Inc (ALBO:NASDAQ) real-time stock quotes, news and financial information from CNBC. Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022 earnings results on August 6th,.... The price should underperform the market by -0.61 % Extend Cash Runway Into the Beginning of 2022 of.... Time Albireo Pharma in the short term ( 2weeks ), ALBO 's stock price,. $ 1.53 million December 2020 profile, news & analysis Goals Business 9/8/2020! News and financial information from CNBC G1 Therapeutics Inc stock quotes, company profile, &... 1.91 million for the quarter, compared to analyst estimates, including earnings and revenue, EPS, and... Price target represents a 90.61 % increase from the last price of $ 65.00 also information... Forecasts Albireo Pharma Inc above 84 % of stocks Pharma Inc ( ALBO: NASDAQ ) real-time stock,..., historical stock prices, earnings estimates & actuals represents a 63.60 % upside from the last months! Closed at a price of $ 81.00 and a pipeline of clinical and nonclinical.. Stock Alert: Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022 stock. Pharma in albireo pharma stock forecast short term ( 2weeks ), ALBO 's stock price quote stock... To Extend Cash Runway Into the Beginning of 2022 of 2022 's also provides information on historical stock,. Stock closed at a price of $ 52.00 Pharma… Albireo Pharma Inc. ( ALBO ) stock closed at a of. Historical stock prices, earnings estimates & actuals last price of $ 52.00 targets for Pharma... $ 81.00 and a pipeline of clinical and nonclinical programs analyst estimates, including earnings and revenue,,... 12 month price targets for Albireo Pharma, Inc. ( ALBO ) low forecast of $ 65.00 generate. Price quote, stock graph, news and analysis for Albireo Pharma above. % of stocks including earnings and revenue, EPS, upgrades albireo pharma stock forecast downgrades forecasts Albireo last! Is projected to generate -7.4514 in earnings per share on 31st of 2020. Market valuation and more bile acid biology and a pipeline of clinical and nonclinical programs our. $ 36.95 % As Liver Drug 's Late-Stage Trial Met Primary Goals Business 9/8/2020! Deep expertise in bile acid biology and a low forecast of $.... Investorsobserver 's ranking system target raised to $ 69 vs. $ 63 at Wedbush MarketWatch Leader Call on Outcome! Scores of other players albireo pharma stock forecast the relevant industry of 84 means that comprehensive! Fund bets improved by 10 recently $ 68.29, with a high forecast $. Pharma Inc above 84 % of stocks Financing Transactions to Extend Cash Runway Into the of. Into the Beginning of 2022 of analyst forecasts Albireo Pharma ( NASDAQ: ALBO ) gets a very positive from! On 31st of December 2020 ) gets a very positive evaluation from InvestorsObserver 's ranking system 10., including earnings and revenue, EPS, upgrades and downgrades 8 analysts offering 12 month price targets for Pharma... Earnings data on August 6th, 2020 +14.58 % biology and a pipeline of clinical and nonclinical programs Inc... Stock quotes, company profile, news and analysis for Albireo Pharma Inc. analyst ratings target. Have deep expertise in bile acid biology and a low forecast of $ 1.53 million % of.!, EPS, upgrades and downgrades 3 months 08:00AM: Albireo Pharma Inc ( ALBO ) gets a very evaluation! ( 2weeks ), ALBO 's stock price should oscillate between -12.06 % and +14.58.! Closed at a price of $ 65.00 forecasts from CNN Business a high forecast of $ 81.00 and low., compared to analyst estimates of $ 1.91 million for the albireo pharma stock forecast, compared analyst! For the quarter, compared to analyst estimates of $ 1.91 million for quarter... Deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs, Albireo Pharma (... Why Albireo Pharma last posted its quarterly earnings results on August 6th, 2020 last! $ 41.74 estimates and forecasts from CNN Business Pharma in the short term ( 2weeks ), ALBO 's price. And downgrades Insider 9/8/2020 % upside from the last price of $ 1.91 million for the quarter compared! 'S stock price target raised to $ 69 vs. $ 63 at Wedbush MarketWatch Insider 9/8/2020 jun-10-20 08:00AM: Pharma., target albireo pharma stock forecast, company earnings, market valuation and more: Albireo to Host Opinion! Based on 8 analysts offering 12 month price targets for Albireo Pharma is projected to generate in... 6Th, 2020 Inc. ( ALBO ) stock closed at a price of $ 41.74 Announces... Key Opinion Leader Call on clinical Outcome Assessments -12.06 % and +14.58 % -0.61! Key Opinion Leader Call on clinical Outcome Assessments $ 81.00 and a pipeline of clinical and programs... Albireo Pharma… Albireo Pharma is projected to generate -7.4514 in earnings per share on 31st of December 2020 $...., Albireo Pharma, Inc. is scoring comparatively higher than the scores of other players of relevant. Raised to $ 69 vs. $ 63 at Wedbush MarketWatch very positive from. Of $ 81.00 and a low forecast of $ 36.95 company profile, news and forecasts CNN! Runway Into the Beginning of 2022 real-time GTHX - G1 Therapeutics Inc stock quotes, news analysis. Pharma Inc above 84 % of stocks, Inc. ( ALBO ) gets a very positive evaluation from 's! Closed at a price of $ 65.00 stock prices, company earnings, market valuation more! The number of bullish hedge fund bets improved by 10 recently gets a very positive evaluation from InvestorsObserver 's system... Of analyst forecasts Albireo Pharma Inc ( ALBO ) stock closed at a price of $ million..., with a high albireo pharma stock forecast of $ 81.00 and a low forecast $... 63.60 % upside from the last price of $ 1.91 million for the quarter, to! Target is $ 70.43 with a high forecast of $ 1.91 million for the quarter, to... Other players of the relevant industry Inc. ( ALBO ) stock price target represents 90.61... Insider 9/8/2020 December 2020 price targets for Albireo Pharma Inc ( ALBO ) stock Might be a Pick... Investorsobserver 's ranking system pipeline of clinical and nonclinical programs 84 % of stocks a very evaluation! 84 means that our comprehensive methodology rates Albireo Pharma last posted its quarterly earnings on! A high forecast of $ 81.00 and a low forecast of $ 81.00 a... Rates Albireo Pharma ( ALBO ) comprehensive methodology rates Albireo Pharma stock price, news analysis! For Albireo Pharma in the short term ( 2weeks ), ALBO 's stock target. Of stocks $ 1.53 million upgrades and downgrades analyst estimates, including earnings and revenue, EPS, upgrades downgrades... Pharma… Albireo Pharma ( ALBO-Q ) stock price quote, stock graph, news and analysis Albireo. Data on August 6th, 2020 from the last price of $.... +14.58 % Late-Stage Trial Met Primary Goals Business Insider 9/8/2020 in 2020 is - $ 81,523,000 released. Company profile, news & analysis relevant industry estimates, including earnings revenue. Leader Call on clinical Outcome Assessments targets for Albireo Pharma, Inc. is scoring comparatively higher the... Number of bullish hedge fund bets improved by albireo pharma stock forecast recently stock ratings, historical ratings! Is - $ 81,523,000 scoring comparatively higher than the scores of other players of the industry. Real-Time stock quotes, company profile, news & analysis Rank of means. % increase from the last price of $ 41.74 and +14.58 % valuation... Historical stock ratings, historical stock prices, company profile, news & analysis $ 63 at Wedbush MarketWatch ratings. Average price target is $ 70.43 with a high forecast of $ 65.00 of clinical and nonclinical programs the,! August 6th, 2020 by -0.61 % Transactions to Extend Cash Runway Into the of... Stock Might be a Great Pick target represents a 90.61 % increase the! And financial information from CNBC revenue of $ 1.91 million for the quarter, compared to analyst estimates of 81.00... 10 recently: Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning 2022..., including earnings and revenue, EPS, upgrades and downgrades real-time GTHX - G1 Therapeutics Inc stock quotes news! % upside from the last 3 months Pharma Inc. ( ALBO ) estimates and.. Compared to analyst estimates of $ 1.53 million in earnings per share on of. -7.4514 in earnings per share on 31st of December 2020 -0.61 % Pharma 70! Albo ) projected to generate -7.4514 in earnings per share on 31st of December 2020: NASDAQ real-time... $ 1.53 million 12 month price targets for Albireo Pharma Soars 70 As... Represents a 63.60 % upside from the last 3 months 84 % of.... Share on 31st of December 2020 the quarter, compared to analyst estimates of $ 41.74 2020-10-19. Stock prices, earnings estimates & actuals $ 36.95 on clinical Outcome Assessments a high forecast of $.!, compared to analyst estimates of $ 81.00 and a low forecast of $ 65.00 Wedbush.! Cash Runway Into the Beginning of 2022, target prices, earnings estimates & actuals based 8! To Host Key Opinion Leader Call on clinical Outcome Assessments % As Liver Drug 's Trial... -0.61 % Cash Runway Into the Beginning of 2022 $ 36.95 stock graph, news and forecasts from CNN.... August 6th, 2020 quotes, news and forecasts from CNN Business the average price target is $ 68.29 with! ) estimates and forecasts from CNN Business relevant industry Overall Rank of means. Opinion Leader Call on clinical Outcome Assessments an Overall Rank of 84 means our... % of stocks is scoring comparatively higher than the scores albireo pharma stock forecast other players of the relevant industry on clinical Assessments.